Treatment Registry
TR-0654 ActiveRecorded September 2, 2026

Oral semaglutide

Sold by Peptivo · every oral semaglutide record

The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.

What you actually pay

Per month

$249

Medication · Semaglutide Oral+, starting price$249

Added from the figures recorded below.

Price

TermPer monthCharged today
Semaglutide Oral+, starting price

Semaglutide Oral+ High Dose Compounded Oral Medication for Advanced Therapy from $249

source

Per month$249Charged today$249
Visit Peptivo

We earn nothing from this link. Peptivo has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.

History

One reading so far. A price history appears here after the next verification pass.

  • September 2, 2026Entry added to the register

Sourcing and terms

StatesAll 50 states
PrescriberAsynchronous review
Cancellation“If a subscription is canceled after a charge has been processed: Cancellation will prevent future charges, but previously processed charges are non-refundable.”

Not yet checked: pharmacy, membership and consult fee.

Recorded from peptivo.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. September 2, 2026'No Hidden Fees. No Membership Cost' is stated repeatedly, and the per-day medication prices appear to be all-inclusive, so no separate membership entry was recorded. The 'Tirzepatide Oral' SKU has no matching enum ('oral tirzepatide' doesn't exist on this register); recorded as compounded tirzepatide since the page tags it COMPOUNDED. Semaglutide Oral+ and both injections don't state vial vs. pen or tablet vs. sublingual, so form is not-disclosed throughout.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0654
Readings
1

Related records

What else Peptivo sells

All Peptivo programs and terms

Oral semaglutide at a similar price

The records either side of this one in the recorded spread. Not a ranking, and not a recommendation — a position among 55 records of the same molecule.

Cite this entry

Treatment Registry. (2026). Peptivo oral semaglutide (TR-0654). Last verified September 2, 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0654

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.